Why Coupa Software Is Trading Higher By Over 12%; Here Are 24 Stocks Moving Premarket

Loading...
Loading...

Gainers

  • Biophytis S.A. BPTS shares rose 41.5% to $1.33 in pre-market trading after the company announced data on Covid treatment.
  • bioAffinity Technologies, Inc. BIAF rose 26.4% to $6.81 in pre-market trading after dropping around 24% on Tuesday. The company, last week, priced its IPO at $6.125 per unit.
  • Spero Therapeutics, Inc. SPRO shares rose 20.4% to $1.36 in pre-market trading. Spero Therapeutics shares jumped over 55% on Tuesday after the company received minutes from a Type A meeting with the FDA discussing steps required to resubmit the marketing application for tebipenem HBr.
  • Coupa Software Incorporated COUP rose 12.2% to $62.60 in pre-market trading as the company posted better-than-expected results for its second quarter and issued strong forecast for FY23. The company also announced a $100 million buyback program.
  • Edgio, Inc.. EGIO rose 11.7% to $3.81 in pre-market trading. Edgio, last month, named Stephen Cumming as Chief Financial Officer and Rich Diegnan as Chief Legal Officer.
  • Baudax Bio, Inc. BXRX rose 10.6% to $0.3330 in pre-market trading after declining over 7% on Tuesday. Baudax Bio recently announced the pricing of a $6.2 million public offering.
  • Pioneer Power Solutions, Inc. PPSI rose 10.4% to $3.90 in pre-market trading. Pioneer Power Solutions, last month, said Q2 EPS results were down year over year.
  • CF Acquisition Corp. VI CFVI rose 10% to $14.68 in pre-market trading after gaining around 14% on Tuesday.
  • Rigetti Computing, Inc. RGTI rose 9.2% to $2.50 in pre-market trading after dropping 37% on Tuesday.
  • Aquestive Therapeutics, Inc. AQST rose 8% to $1.35 in pre-market trading. Oppenheimer initiated coverage on Aquestive Therapeutics with an Outperform rating and announced a price target of $8.5.
  • Maverix Metals Inc. MMX rose 7.4% to $3.64 in pre-market trading.
  • Bright Minds Biosciences Inc. DRUG rose 7.1% to $1.97 in pre-market trading after declining around 5% on Tuesday.


Don’t forget to check out our premarket coverage here .

Losers

  • NewAge, Inc. NBEV shares fell 32.3% to $0.0846 in pre-market trading after dipping over 15% on Tuesday. The company recently announced it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code.
  • CleanTech Acquisition Corp. CLAQ shares fell 21.8% to $7.39 in pre-market trading after the company reported shareholder voting results in 8K filing.
  • UiPath Inc. PATH fell 21.1% to $12.30 in pre-market trading after the company issued Q3 and FY23 sales guidance below analyst estimates.
  • Shuttle Pharmaceuticals Holdings, Inc. SHPH fell 17.5% to $23.50 in pre-market trading after jumping 91% on Tuesday.
  • Bit Brother Limited BTB fell 11.1% to $0.1423 in pre-market trading.
  • Allena Pharmaceuticals, Inc. ALNA fell 10.9% to $0.0648 in pre-market trading. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.
  • ThermoGenesis Holdings, Inc. THMO fell 9.2% to $0.1770 in pre-market trading after declining around 9% on Tuesday. ThermoGenesis, last month, posted a Q2 loss of $0.20 per share.
  • DBV Technologies S.A. DBVT fell 8.1% to $2.16 in pre-market trading after gaining around 8% on Tuesday. DBV Technologies, last month, posted a Q2 loss of $0.35 per share.
  • First Wave BioPharma, Inc. FWBI fell 7.8% to $3.89 in pre-market trading after jumping around 33% on Tuesday. First Wave BioPharma recently announced a 1:30 reverse stock split.
  • Apexigen, Inc. APGN shares fell 7.2% to $6.52 in pre-market trading after gaining 34% on Tuesday.
  • Digital World Acquisition Corp. DWAC fell 6.3% to $20.71 in pre-market trading. DWAC shares dropped over 11% on Tuesday following reports suggesting the shareholders have rejected the special purpose acquisition company's proposal to extend the deadline by a year for its merger with Donald Trump's Trump Media & Technology.
  • NIO Inc. NIO fell 5.3% to $16.19 in pre-market trading after reporting Q2 results. NIO also said it sees Q3 revenue of $1,918 billion to $2,030 billion.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...